Precision BioSciences Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.8% | +15.6% | -10.3% | -7.6% | -11.0% | -8.8% | -12.4% | -14.2% | +65.1% | -6.8% | -12.5% | |
| – | -6.5% | +17.9% | -10.4% | -23.3% | -14.1% | -13.6% | -14.4% | -26.4% | +129.6% | -8.5% | -15.8% | |
| – | -4.5% | +18.1% | -10.3% | -20.1% | -13.0% | -10.1% | -19.4% | -27.9% | +147.0% | -10.3% | -13.4% | |
| – | -4.5% | +18.1% | -10.3% | -18.1% | -14.7% | -10.5% | -19.4% | -27.9% | +157.6% | -12.5% | -13.5% | |
| – | -15.8% | +3.9% | +3.9% | -88.8% | +9.8% | -99.8% | +143,150.0% | -99.9% | -100.0% | – | -100.0% | |
| – | – | – | – | – | – | – | -0.3% | – | – | – | – | |
| – | -59.1% | -3.5% | -2.8% | +3.5% | +60.3% | -2.4% | -0.3% | +62.8% | +18.4% | -3.3% | -3.0% | |
| – | +4.2% | +4.7% | -38.3% | -3.0% | -9.5% | -6.2% | -0.3% | +2.7% | -19.1% | +9.0% | +18.9% | |
| – | -1.2% | -33.3% | -1.1% | -63.6% | +25.0% | -17.3% | +9.5% | +10.5% | -40.6% | -13.0% | -7.9% | |
| – | -1.3% | +0.4% | +0.3% | -94.6% | +3.5% | +3.4% | +3.4% | +3.3% | +3.4% | +3.3% | +3.3% | |
| – | +458.9% | -61.7% | +0.7% | -16.3% | +37.0% | -29.6% | +21.3% | +19.5% | -77.9% | +218.9% | -12.3% | |
| – | – | – | – | – | +0.2% | +0.1% | +0.1% | +0.1% | +0.1% | – | – | |
| – | -35.1% | +97.3% | +100.8% | -13.2% | -13.1% | -12.5% | -31.0% | -51.2% | +454.6% | -17.5% | -40.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +16.0% | +13.7% | +38.5% | +3.9% | -5.5% | +30.2% | +23.2% | +7.0% | +62.2% | +28.5% | +5.0% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.